Aims and Scope:
European Journal of Molecular & Clinical Medicine (EJMCM) (formely know as New Horizons in Translational Medicine Published by Elseiver) is an open access online journal publishing high quality manuscripts covering all aspects of molecular and clinical medicine. Submitted manuscripts are peer reviewed and selection is based on scientific excellence, distinctive contribution to knowledge and importance to the field.
Molecular Medicine Section: Special consideration will be given to novel findings generated in cellular and molecular biology, genetics, stem cell biology, microbiology, immunology and the omics disciplines. In addition, quality manuscripts describing novel developments in the field of biomarkers, disease modelling, large data set mining will be considered for publication.
Clinical Medicine Section: Special consideration will be given to high quality clinical studies and case reports from all clinical specialties. Manuscripts should provide new insight and contribute to advance medical knowledge.
Distinctions: The most widely read, cited, and known Molecular & Clinical Medicine journal and website is well browsed with all the articles published. More than 30,000 readers per month.
ISSN: 2515-8260 ; Frequency: Rapid at a time publication (6 issues/year)
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
Open Access Journal: European Journal of Molecular & Clinical Medicine is an open access journal, which allows authors to fund their article to be open access from publication.